American Financial Network Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-4,435
Closed -$476K 106
2019
Q2
$476K Sell
4,435
-465
-9% -$49.5K 0.37% 76
2019
Q1
$533K Sell
4,900
-501
-9% -$55K 0.39% 73
2018
Q4
$521K Sell
5,401
-2,470
-31% -$262K 0.37% 83
2018
Q3
$960K Buy
7,871
+7,822
+15,963% +$921K 0.51% 59
2018
Q2
$931 Buy
49
+1
+2% +$107 0.51% 60
2018
Q1
$859 Sell
48
-10,611
-100% -$1.18M 0.45% 64
2017
Q4
$1.14M Buy
10,659
+3,039
+40% +$325K 0.48% 63
2017
Q3
$847K Buy
+7,620
New +$814K 0.36% 88

Other funds holding IBB

American Financial Network Advisory Services's IBB Position: Q3 2019 in Review

American Financial Network Advisory Services sold out of iShares Biotechnology ETF (IBB) in Q3 2019, closing a stake of 4,435 shares — an estimated $476K sold.

American Financial Network Advisory Services first reported a position in IBB in Q3 2017 and held it in 8 quarters. The position peaked at $1.14M in Q4 2017. 597 funds tracked by Wall St. Rank hold IBB as of Q3 2019.

  • American Financial Network Advisory Services reported no remaining iShares Biotechnology ETF position as of Q3 2019 after selling out during the quarter.
  • American Financial Network Advisory Services sold 4,435 iShares Biotechnology ETF shares in Q3 2019, an estimated $476K.
  • American Financial Network Advisory Services first reported a position in iShares Biotechnology ETF in Q3 2017 and held it in 8 quarters.
  • American Financial Network Advisory Services's iShares Biotechnology ETF position peaked at $1.14M in Q4 2017.
  • 597 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2019.

Based on American Financial Network Advisory Services's 13F filing for Q3 2019, filed 12 Nov 2019.